Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial

This randomized controlled trial evaluated clinical durability of Zilver PTX, a paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions. Outcomes compare primary DES versus percutaneous transluminal angioplasty (PTA), overall DES (primary and provisional) versus standard care...

Full description

Saved in:

Bibliographic Details
Published in:	Circulation (New York, N.Y.) Vol. 133; no. 15; pp. 1472 - 83; discussion 1483
Main Authors:	Dake, Michael D, Ansel, Gary M, Jaff, Michael R, Ohki, Takao, Saxon, Richard R, Smouse, H Bob, Machan, Lindsay S, Snyder, Scott A, O'Leary, Erin E, Ragheb, Anthony O, Zeller, Thomas
Format:	Journal Article
Language:	English
Published:	United States 12.04.2016
Subjects:	Adult Aged Angioplasty Anticoagulants - therapeutic use Arterial Occlusive Diseases - drug therapy Arterial Occlusive Diseases - therapy Aspirin - therapeutic use Clopidogrel Combined Modality Therapy Disease Progression Disease-Free Survival Drug-Eluting Stents Equipment Failure Female Femoral Artery - drug effects Follow-Up Studies Humans Intermittent Claudication - therapy Ischemia - surgery Ischemia - therapy Male Middle Aged Paclitaxel - administration & dosage Paclitaxel - therapeutic use Popliteal Artery - drug effects Recurrence Stents Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Vascular Patency paclitaxel drug-eluting stents peripheral artery disease stents angioplasty
ISSN:	1524-4539
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!